These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 9710669)

  • 1. Antibiotic resistance caused by gram-negative multidrug efflux pumps.
    Nikaido H
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S32-41. PubMed ID: 9710669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AcrAB and related multidrug efflux pumps of Escherichia coli.
    Nikaido H; Zgurskaya HI
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):215-8. PubMed ID: 11321576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model of a transmembrane drug-efflux pump from Gram-negative bacteria.
    Fernandez-Recio J; Walas F; Federici L; Venkatesh Pratap J; Bavro VN; Miguel RN; Mizuguchi K; Luisi B
    FEBS Lett; 2004 Dec; 578(1-2):5-9. PubMed ID: 15581607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance mechanisms: drug efflux across two membranes.
    Zgurskaya HI; Nikaido H
    Mol Microbiol; 2000 Jul; 37(2):219-25. PubMed ID: 10931319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of solvent tolerance in gram-negative bacteria.
    Ramos JL; Duque E; Gallegos MT; Godoy P; Ramos-Gonzalez MI; Rojas A; Teran W; Segura A
    Annu Rev Microbiol; 2002; 56():743-68. PubMed ID: 12142492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors.
    Zgurskaya HI; Walker JK; Parks JM; Rybenkov VV
    Acc Chem Res; 2021 Feb; 54(4):930-939. PubMed ID: 33539084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyamine effects on antibiotic susceptibility in bacteria.
    Kwon DH; Lu CD
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.
    Abdali N; Parks JM; Haynes KM; Chaney JL; Green AT; Wolloscheck D; Walker JK; Rybenkov VV; Baudry J; Smith JC; Zgurskaya HI
    ACS Infect Dis; 2017 Jan; 3(1):89-98. PubMed ID: 27768847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors.
    Vila J; Martínez JL
    Curr Drug Targets; 2008 Sep; 9(9):797-807. PubMed ID: 18781925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RND efflux pump mediated antibiotic resistance in Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa: a major issue worldwide.
    Puzari M; Chetia P
    World J Microbiol Biotechnol; 2017 Feb; 33(2):24. PubMed ID: 28044273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of efflux pump-based antibiotic resistance.
    Zgurskaya HI
    Int J Med Microbiol; 2002 Jul; 292(2):95-105. PubMed ID: 12195740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial antibiotic efflux systems of medical importance.
    Köhler T; Pechère JC; Plésiat P
    Cell Mol Life Sci; 1999 Nov; 56(9-10):771-8. PubMed ID: 11212337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump.
    Sánchez L; Pan W; Viñas M; Nikaido H
    J Bacteriol; 1997 Nov; 179(21):6855-7. PubMed ID: 9352940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for efflux pump systems of bacteria by the new acridine orange agar method.
    Martins A; Amaral L
    In Vivo; 2012; 26(2):203-6. PubMed ID: 22351659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.
    Blair JM; Richmond GE; Piddock LJ
    Future Microbiol; 2014; 9(10):1165-77. PubMed ID: 25405886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobavachalcone and diospyrone.
    Kuete V; Ngameni B; Tangmouo JG; Bolla JM; Alibert-Franco S; Ngadjui BT; Pagès JM
    Antimicrob Agents Chemother; 2010 May; 54(5):1749-52. PubMed ID: 20160051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic resistance of Escherichia coli to mureidomycin A and C due to expression of the multidrug efflux system AcrAB-TolC: comparison with the efflux systems of mureidomycin-susceptible Pseudomonas aeruginosa.
    Gotoh N; Murata T; Ozaki T; Kimura T; Kondo A; Nishino T
    J Infect Chemother; 2003 Mar; 9(1):101-3. PubMed ID: 12673418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.
    Schweizer HP
    Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug efflux pumps of gram-negative bacteria.
    Nikaido H
    J Bacteriol; 1996 Oct; 178(20):5853-9. PubMed ID: 8830678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.